In this research, we will analyze the effect of selective alpha-2 receptor agonists on the human eye and investigate ocular changes over 6 months after its topical use.
Age
18–50
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Glaucoma suspect cases.
post-refractive surgery cases.
You may not be if
Cases with prostatic hyperplasia or diabetics that may alter the measurements of pupillary diameter.
Cases with previous history of any retinal intervention or other drugs that may alter intraocular pressure measurements.
Clareo Health | Ocular Changes With Alpha-2 Receptor Agonist.
